Author

D. Gilot

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Research Focus:clustering· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

L. Bachelot· 2 shared M. Aubry· 2 shared A. Houel· 1 shared A. L'Haridon· 1 shared A. M. Quemener· 1 shared A. Primot· 1 shared A. Prouteau· 1 shared B. Hedan· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. Bachelot

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma

P. Papoutsoglou, C. Louis, R. Pineau, A. L'Haridon, J. M. Banales, D. Gilot, M. Aubry, C. Coulouarn

This study identifies LINC00313 as a TGFβ-induced lncRNA that activates Wnt signaling and promotes cholangiocarcinoma through interactions with SWI/SNF and regulation of TCF7 and SULF2.

bioRxiv · Sep 28, 2022 · PreprintCancer Biology

Uveal Melanoma: a miR-16 disease?

A. M. Quemener, L. Bachelot, M. Aubry, S. Avner, D. Leclerc, G. Salbert, F. Cabillic, D. Decaudin, B. Mari, F. Mouriaux, M.-D. Galibert, D. Gilot

This study identifies miR-16's non-canonical role in uveal melanoma by sequestering sponge RNAs, leading to oncogene derepression and poor survival, with a sponge-signature outperforming current methods.

bioRxiv · Nov 30, 2021Cancer Biology

Canine oral melanoma genomic and transcriptomic study defines two molecular subgroups with different therapeutical targets

A. Prouteau, S. Mottier, A. Primot, E. Cadieu, L. Bachelot, N. Botherel, F. Cabilic, A. Houel, L. Cornevin, C. Kergal, S. Corre, J. Abadie, C. Hitte, D. Gilot, K. Lindblad-Toh, , B. Hedan

This study identifies two molecular subgroups of canine oral melanoma with distinct therapeutic targets, suggesting potential for tailored treatments in humans.

bioRxiv · Aug 4, 2021Cancer Biology